Internal Medicine, Nephrology · Altamonte Springs, FL
NPI
1770576845
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
685 Palm Springs Dr, Suite 1b
Altamonte Springs, FL, 32701
Phone (407) 339-4447
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
4,153 services
Medicare patients, 2024
784
Average age 76
Drug cost, 2024
$717K
3,177 prescriptions
Company payments, 2025
$258
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vasudeva R Bommineni was code 99232 (hospital e&m - subsequent), 820 times for 258 patients. In total Vasudeva R Bommineni billed 4,153 services in 45 codes, and Medicare paid $226K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 820 | 258 | $60.72 | $50K |
| 99214 Office E&M - Established | Office | 752 | 409 | $66.10 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 511 | 325 | $12.75 | $6,516 |
| 99222 Hospital E&M - Initial | Facility | 207 | 172 | $100.99 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 192 | 109 | $92.29 | $18K |
| 90935 Hemodialysis | Facility | 150 | 62 | $54.54 | $8,181 |
| 90960 ESRD Related Services (not dialysis) | Office | 121 | 23 | $272.75 | $33K |
| 99309 SNF E&M | Facility | 78 | 37 | $82.68 | $6,449 |
| 99223 Hospital E&M - Initial | Facility | 78 | 78 | $133.75 | $10K |
| 99204 Office E&M - New | Office | 72 | 72 | $113.03 | $8,138 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 31 | 25 | $42.37 | $1,314 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 17 | 12 | $37.10 | $631 |
| 99308 SNF E&M | Facility | 17 | 13 | $57.56 | $979 |
By year: 2022 $330K for 16,203 services; 2023 $273K for 8,647 services; 2024 $226K for 4,153 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 150 | 19 | $2.32 | $348 |
Medicare prescription drug claims, 2024
In 2024, the drug Vasudeva R Bommineni prescribed most often to Medicare patients was Furosemide, with 258 prescriptions and refills. In total Vasudeva R Bommineni wrote 3,177 Medicare prescriptions that cost $717K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 258 | 444 | 77 | $1,110 |
| Allopurinol Generic | 255 | 479 | 63 | $1,791 |
| Jardiance Empagliflozin | 253 | 332 | 56 | $190K |
| Amlodipine Besylate Generic | 151 | 297 | 43 | $668 |
| Potassium Chloride Generic | 141 | 265 | 40 | $2,089 |
| Losartan Potassium Generic | 133 | 243 | 34 | $969 |
| Tamsulosin Hcl Generic | 133 | 284 | 36 | $1,258 |
| Spironolactone Generic | 114 | 244 | 37 | $995 |
| Farxiga Dapagliflozin Propanediol | 102 | 156 | 24 | $85K |
| Hydralazine Hcl Generic | 93 | 192 | 31 | $1,122 |
| Lokelma Sodium Zirconium Cyclosilicate | 85 | 116 | 25 | $61K |
| Lisinopril Generic | 65 | 156 | 22 | $256 |
| Finasteride Generic | 61 | 113 | 14 | $379 |
| Hydrochlorothiazide Generic | 60 | 116 | 19 | $262 |
| Clonidine Generic | 54 | 75 | Under 11 | $3,825 |
Brand drugs: 709 claims; generic drugs: 2,468 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vasudeva R Bommineni $258 ($258 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $161.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.